首页> 美国卫生研究院文献>BMJ Open >Controlled ovarian hyperstimulation for poor ovarian responders undergoing in vitro fertilisation/intracytoplasmic sperm injection: a protocol for systematic review and Bayesian network meta-analysis
【2h】

Controlled ovarian hyperstimulation for poor ovarian responders undergoing in vitro fertilisation/intracytoplasmic sperm injection: a protocol for systematic review and Bayesian network meta-analysis

机译:受控卵巢过度刺激对体外施肥的贫困卵巢响应者/氏卵体精子注射:系统审查和贝叶斯网络荟萃分析的协议

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Controlled ovarian hyperstimulation (COH) is the routine regimen used to generate a sufficient number of follicles during in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) treatment. Poor ovarian response is a challenge encountered by many clinicians during COH and poor ovarian responders (PORs) usually have higher follicle stimulating hormone levels, lower levels of anti-Mullerian hormone and few oocytes retrieved, which have been attributed mainly to advanced maternal age and poor follicle reserve or other reasons that could impair ovarian response during ovarian stimulation. Over the last few decades, researchers have proposed a series of strategies and ovarian stimulation protocols to improve pregnancy outcomes in patients with POR during their IVF/ICSI treatment. However, clinical decisions regarding COH protocols in PORs during IVF/ICSI treatment remain controversial. Traditional pairwise meta-analysis only allows the direct comparison of two protocols in COH for patients with POR. However, many of these COH protocols have not been compared directly in randomised controlled trials (RCTs). Thus, we aim to use network meta-analysis (NMA) to assess the clinical effectiveness and safety of COH protocols and to generate treatment rankings of these COH protocols for the most clinically important and commonly reported outcomes events.
机译:受控卵巢过度刺激(COH)是用于在体外施肥期间产生足够数量的卵泡的常规方案(IVF)或氏菌药物注射(ICSI)治疗。卵巢反应不佳是在COH和卵巢癌症患者(PORS)期间许多临床医生遇到的挑战通常具有较高的卵泡刺激激素水平,降低抗Mullerian激素和少量检索的卵母细胞,这主要归因于先进的产妇年龄和穷人卵泡储备或可能损害卵巢刺激期间卵巢反应的其他原因。在过去的几十年中,研究人员提出了一系列策略和卵巢刺激方案,以改善在IVF / ICSI治疗期间POR患者的妊娠结果。但是,关于IVF / ICSI治疗期间PORS中的COH议定书的临床决定仍存在争议。传统的成对荟萃分析仅允许对POR患者的COH中的两种协议直接比较。然而,许多这些COH协议尚未直接在随机对照试验(RCT)中进行比较。因此,我们的目标是使用网络元分析(NMA)来评估COH协议的临床效果和安全性,并在最临床上重要和常见的结果事件中产生这些核准议定书的治疗排名。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号